The cancer biomarker problem.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18385728.
- Also identified by DOI 10.1038/nature06913.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Genomic technologies offer the promise of a comprehensive understanding of cancer. These technologies are being used to characterize tumours at the molecular level, and several clinical successes have shown that such information can guide the design of drugs targeted to a relevant molecule. One of the main barriers to further progress is identifying the biological indicators, or biomarkers, of cancer that predict who will benefit from a particular targeted therapy.
Medical subject headings
- Biomarkers, Tumor
- Neoplasms